This correlation between overexpression of FSTL3 and poor outcome may not be unique to ascites nor ovarian cancer as it was also observed at the transcriptional level across multiple solid tumor types including pancreatic, lung, and colorectal cancers through analysis of data from the TCGA. This evidence concerns the gene FSTL3 and ovarian cancer.